focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Regulatory News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding in Company

22 Sep 2017 14:01

RNS Number : 5998R
Silence Therapeutics PLC
22 September 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Silence Therapeutics plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Aviva plc & its subsidiaries

City and country of registered office (if applicable)

London, England

4. Full name of shareholder(s) (if different from 3.)v

Name

Registered Holder:

Chase (GA Group) Nominees Limited 2,651,683*

 

HSBC Global Custody Nominee (UK) Limited 651,949*

State Street Nominees Limited 50,617*

Available on Request 7,076*

*denotes direct interest

 

Chase (GA Group) Nominees Limited 119,537

 

Chase Nominees Limited 55,444

 

Vidacos Nominees Limited 156,300

 

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

20/09/2017

6. Date on which issuer notified (DD/MM/YYYY):

21/09/2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

5.28%

5.28%

69,991,624

Position of previous notification (if

applicable)

6.39%

6.39%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary SharesGB00B9GTXM62

3,361,325

331,281

4.80%

0.48%

SUBTOTAL 8. A

3,692,606

5.28%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Aviva plc

5.28%

5.28%

Aviva Group Holdings Limited

5.28%

5.28%

Aviva Investors Holdings Limited

5.27%

5.27%

Aviva Investors Global Services Limited

5.27%

5.27%

Aviva plc

5.28%

5.28%

Aviva Group Holdings Limited

5.28%

5.28%

Friends Provident

International Limited

10. In case of proxy voting, please identify:

Name of the proxy holder

See Section 4

The number and % of voting rights held

The date until which the voting rights will be held

 

 

 

 

11. Additional informationxvi

This notification is prompted by a 5% to 4% change at Direct Interest Level (Box 8A)

 

Place of completion

Norwich, England

Date of completion

21 September 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPGURABUPMGPP
Date   Source Headline
17th May 20115:39 pmPRNTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
17th May 20115:38 pmPRNTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
17th May 20115:38 pmPRNTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
16th May 20113:36 pmPRNGrant of options and warrants
16th May 20112:30 pmPRNResult of General Meeting
16th May 20117:00 amPRNResults of Placing and Open Offer
12th May 20115:42 pmPRNTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
27th Apr 20117:06 amPRNPlacing and Open Offer of New Ordinary Shares
27th Apr 20117:01 amPRNFull Year Results for the Year Ended 31 December 2010
26th Apr 20114:40 pmRNSSecond Price Monitoring Extn
26th Apr 20114:35 pmRNSPrice Monitoring Extension
7th Apr 20114:40 pmRNSSecond Price Monitoring Extn
7th Apr 20114:35 pmRNSPrice Monitoring Extension
7th Apr 20111:37 pmRNSTR-1: Notification of Major Interest in Shares
4th Apr 20114:40 pmRNSSecond Price Monitoring Extn
4th Apr 20114:35 pmRNSPrice Monitoring Extension
21st Mar 20118:00 amRNSPF-04523655 Phase 2 Study Results
14th Feb 20114:35 pmRNSPrice Monitoring Extension
7th Feb 20117:00 amRNSOffer Update
21st Dec 20107:00 amRNSYear-end Update
17th Nov 20104:40 pmRNSSecond Price Monitoring Extn
17th Nov 20104:35 pmRNSPrice Monitoring Extension
16th Nov 20104:40 pmRNSSecond Price Monitoring Extn
16th Nov 20104:35 pmRNSPrice Monitoring Extension
15th Nov 20104:40 pmRNSSecond Price Monitoring Extn
15th Nov 20104:35 pmRNSPrice Monitoring Extension
12th Nov 20102:53 pmPRNForm 8.3 - Silence Therapeutics Plc
12th Nov 20101:35 pmBUSForm 8.3 - Silence Therapeutics plc
11th Nov 20101:54 pmPRNForm 8.3 - Silence Therapeutics Plc
11th Nov 201011:49 amRNSHolding in Company
11th Nov 20107:28 amBUSForm 8.3 - Silence Therapeutics plc
5th Nov 20104:40 pmRNSSecond Price Monitoring Extn
5th Nov 20104:35 pmRNSPrice Monitoring Extension
22nd Oct 20107:53 amBUSForm 8.3 - Silence Therapeutics plc
21st Oct 20109:23 amBUSForm 8.3 - Silence Therapeutics plc
20th Oct 20104:40 pmRNSSecond Price Monitoring Extn
20th Oct 20104:40 pmRNSSecond Price Monitoring Extn
20th Oct 20104:35 pmRNSPrice Monitoring Extension
20th Oct 20104:35 pmRNSPrice Monitoring Extension
20th Oct 20103:35 pmBUSForm 8.3 - Silence Therapeutics plc
20th Oct 20107:00 amRNSSilence Therapeutics Receives European RNAi Patent
19th Oct 20101:21 pmBUSForm 8.3 - Silence Therapeutics plc
18th Oct 20104:40 pmRNSSecond Price Monitoring Extn
18th Oct 20104:35 pmRNSPrice Monitoring Extension
15th Oct 20104:27 pmBUSForm 8.3 - Silence Therapeutics plc - Replacement
15th Oct 20104:27 pmBUSForm 8.3 - Silence Therapeutics plc - Replacement
15th Oct 20102:28 pmBUSForm 8.3 - Silence Therapeutics plc
15th Oct 20101:52 pmBUSForm 8.3 - Silence Therapeutics plc
12th Oct 20104:35 pmRNSPrice Monitoring Extension
11th Oct 20105:04 pmBUSForm 8.3 - Silence Therapeutics plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.